A single position mutation, V6A, released in the molecule greatly enhanced the toxicity profile and diminished VLS when compared with the WT molecule [76]. Supplemental experiments and medical trials will be important to determine if this modified construct has enhanced safety and efficacy in human beings.This medication could potentially cause kid